[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8800935A1 - Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona - Google Patents

Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Info

Publication number
ES8800935A1
ES8800935A1 ES554429A ES554429A ES8800935A1 ES 8800935 A1 ES8800935 A1 ES 8800935A1 ES 554429 A ES554429 A ES 554429A ES 554429 A ES554429 A ES 554429A ES 8800935 A1 ES8800935 A1 ES 8800935A1
Authority
ES
Spain
Prior art keywords
procedure
obtaining
piridona
derivatives
tricycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554429A
Other languages
English (en)
Other versions
ES554429A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES554429A0 publication Critical patent/ES554429A0/es
Publication of ES8800935A1 publication Critical patent/ES8800935A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE BI Y TRICICLICOS DE PIRIDONA. CONSISTENTE EN DESHIDROHALOGENAR UN COMPUESTO DE FORMULA (II) O (III), PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FISIOLOGICAMENTE ACEPTABLES. SIENDO: Q1, FN-CH-CH-; RA, FENILO, PIRIDILO Y OTROS; RB Y RC, H, HAL Y OTROS; RD, -(A1)M-(CO)N-(Q2A2)Q-R1; M, N Y Q, 0 O 1; A1 Y A2, ALQUILENO INFERIOR; Q2, ATOMO DE OXIGENO O -NR2-; R1, H, OH Y OTROS; R2, H, ARILO Y OTROS; X1, HALOGENO. SE UTILIZA COMO FARMACO ANTICONVULSIVO.
ES554429A 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona Expired ES8800935A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530484 1984-11-06
CH383685 1985-09-05

Publications (2)

Publication Number Publication Date
ES554429A0 ES554429A0 (es) 1987-12-01
ES8800935A1 true ES8800935A1 (es) 1987-12-01

Family

ID=25693960

Family Applications (8)

Application Number Title Priority Date Filing Date
ES548532A Expired ES8705436A1 (es) 1984-11-06 1985-11-05 Un procedimiento para la obtencion de derivados de bi- y triciclicosdde piridona
ES554431A Expired ES8800936A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554432A Expired ES8800937A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554428A Expired ES8800934A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554429A Expired ES8800935A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554427A Expired ES8800933A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554426A Expired ES8800932A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554430A Expired ES8800939A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES548532A Expired ES8705436A1 (es) 1984-11-06 1985-11-05 Un procedimiento para la obtencion de derivados de bi- y triciclicosdde piridona
ES554431A Expired ES8800936A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554432A Expired ES8800937A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554428A Expired ES8800934A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES554427A Expired ES8800933A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554426A Expired ES8800932A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554430A Expired ES8800939A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Country Status (23)

Country Link
US (2) US4735940A (es)
EP (2) EP0183994B1 (es)
JP (1) JPH0692405B2 (es)
CN (1) CN1016871B (es)
AR (1) AR242579A1 (es)
AT (1) ATE51232T1 (es)
AU (1) AU584132B2 (es)
CA (1) CA1277659C (es)
DE (2) DE3587235D1 (es)
DK (1) DK507685A (es)
DO (1) DOP1985004378A (es)
ES (8) ES8705436A1 (es)
FI (1) FI89049C (es)
GB (1) GB2169288B (es)
HU (1) HU205353B (es)
IE (1) IE58850B1 (es)
IL (1) IL76894A (es)
IS (1) IS1469B6 (es)
MC (1) MC1707A1 (es)
MY (1) MY103172A (es)
NO (1) NO171914C (es)
PT (1) PT81431B (es)
ZW (1) ZW17385A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate
DE69123090D1 (de) * 1990-07-06 1996-12-19 Yoshitomi Pharmaceutical Kondensierte Thiophenverbindungen und deren Verwendung
CA2058640A1 (en) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Tricyclic pyridone derivative
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
GB9708945D0 (en) * 1997-05-01 1997-06-25 Merck Sharp & Dohme Therapeutic agents
GB0119828D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
GB0119803D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
KR101421745B1 (ko) 2006-01-13 2014-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 코돈 최적화된 il―15를 사용하는 백신 및 면역치료제, 및 그의 사용 방법
AU2014306271A1 (en) 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191763A (en) * 1978-10-13 1984-05-31 Hoffmann La Roche 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions
EP0067565A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Pharmaceutically active compounds
GB8408292D0 (en) * 1984-03-30 1984-05-10 Fujisawa Pharmaceutical Co Quinolizinone compound
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
GB8509435D0 (en) * 1985-04-12 1985-05-15 Beecham Group Plc Intermediates & process
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines

Also Published As

Publication number Publication date
CN1016871B (zh) 1992-06-03
ES554431A0 (es) 1987-12-01
FI89049C (fi) 1993-08-10
DE3587235D1 (en) 1993-05-06
CN85108120A (zh) 1986-11-05
DOP1985004378A (es) 1991-04-05
ES554429A0 (es) 1987-12-01
ZW17385A1 (en) 1986-02-19
IE852751L (en) 1986-05-06
ES8800939A1 (es) 1987-12-01
ES554426A0 (es) 1987-12-01
HU205353B (en) 1992-04-28
IL76894A0 (en) 1986-02-28
JPH0692405B2 (ja) 1994-11-16
AU4924185A (en) 1986-05-15
EP0183994B1 (de) 1990-03-21
NO854404L (no) 1986-05-07
MC1707A1 (fr) 1986-09-22
IS3054A7 (is) 1986-05-07
DE3576691D1 (de) 1990-04-26
IE58850B1 (en) 1993-11-17
PT81431A (en) 1985-12-01
FI854211A0 (fi) 1985-10-28
FI89049B (fi) 1993-04-30
US5036066A (en) 1991-07-30
US4735940A (en) 1988-04-05
ES554432A0 (es) 1987-12-01
ES8800932A1 (es) 1987-12-01
MY103172A (en) 1993-05-29
ES8705436A1 (es) 1987-05-01
EP0318682B1 (de) 1993-03-31
CA1277659C (en) 1990-12-11
ES8800937A1 (es) 1987-12-01
AR242579A1 (es) 1993-04-30
IL76894A (en) 1989-06-30
GB2169288A (en) 1986-07-09
DK507685A (da) 1986-05-07
JPS61115082A (ja) 1986-06-02
ES8800934A1 (es) 1987-12-01
GB8527196D0 (en) 1985-12-11
ES554430A0 (es) 1987-12-01
ES554427A0 (es) 1987-12-01
EP0318682A3 (en) 1989-08-16
EP0183994A1 (de) 1986-06-11
IS1469B6 (is) 1991-09-24
ES8800933A1 (es) 1987-12-01
ES548532A0 (es) 1987-05-01
ES8800936A1 (es) 1987-12-01
EP0318682A2 (de) 1989-06-07
NO171914C (no) 1993-05-19
ATE51232T1 (de) 1990-04-15
PT81431B (pt) 1988-03-03
ES554428A0 (es) 1987-12-01
NO171914B (no) 1993-02-08
HUT38638A (en) 1986-06-30
GB2169288B (en) 1989-06-01
AU584132B2 (en) 1989-05-18
DK507685D0 (da) 1985-11-04

Similar Documents

Publication Publication Date Title
ES8800935A1 (es) Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
DE3684415D1 (de) Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel.
LU90921I2 (en) Levosimendan (simday)
FR2601366B1 (fr) Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
ES8601934A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
ATE102210T1 (de) 1h,3h,7-pyrrolo (1,2-c>thiazolcarbonsaeureamidderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE54453T1 (de) Cephalosporinderivate.
FI851261L (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
PL255089A1 (en) Method of obtaining novel derivatives of three-ring oxindolocarbonamide
DK540585A (da) 5-alkyl-1-phenyl-2-piperazinoalkylpyrasolin-3-on-forbindelser, fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved, samt farmaceutiske praeparater indeholdende disse forbindelser
EP0242070A3 (en) Phenyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides
NO881466L (no) Fremgangsmaate for fremstilling av 3h-1,2,3-triazolo(4,5-d)pyrimidiner.
ATE13430T1 (de) Neue benzodioxolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE40554T1 (de) Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung.
IL70341A0 (en) Pyrimidone derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine antagonists
ES8800938A1 (es) Procedimiento para preparar derivados berbanicos biologicamente activos.
DE3769333D1 (de) Acylaminomethylimidazo(1,2-a)pyrimidinderivate, ihre herstellung und therapeutische verwendung.
IE38064B1 (en) New 2-amino-4h-pyrane compounds their production and their medicinal use
JO1274B1 (en) Pyridine derivatives
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina
FR2589470B1 (fr) Nouveaux derives de l'imino-3 pyridazine, procede d'obtention et compositions pharmaceutiques
DE3777999D1 (de) Substituierte piperidine oder azepine, ihre herstellung und therapeutische verwendung.
TH1363A (th) สารประกอบเฮเทอโรไซคริค